Molecular testing can now be made available at the point of care

Laboratory-based PCR tests have limited reach in most countries. While rapid antigen tests continue to be highly valuable for wide use as they can be deployed in community clinics and health centres, they lack the sensitivity of molecular tests. The COVID-19 pandemic kick-started development of a new generation of affordable, highly portable devices that could plug this gap by enabling molecular and multi-disease testing in primary care – essential for both disease surveillance and patient care.

FIND is actively monitoring the pipeline of molecular point-of-care platforms and maintains an open-access test directory, as well as working with partners to support promising products and accelerate their development.

Explore the molecular point-of-care tools at Diagnostics Day 2024

Find out more about the tools on display at the event.

DxConnect Molecular point-of-care (POC) test directory

Test directory: molecular point-of-care platforms

A searchable directory for molecular point-of-care platforms focusing on true POC platforms that enable molecular testing at the lowest level healthcare settings, such as primary care, as well as community and at-home testing.

Diagnostics Day 2024

Check out our full agenda for Diagnostics Day.